BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:http://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20230101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240521
DTEND;VALUE=DATE:20240524
DTSTAMP:20260515T225136
CREATED:20240208T111843Z
LAST-MODIFIED:20240208T112145Z
UID:38632-1716249600-1716508799@www.pharmajournalist.com
SUMMARY:6th Annual Treg-Directed Therapies Summit
DESCRIPTION:Driving Next Gen Treg Stimulation for Autoimmunity\, Transplantation & Inflammation \nReturning to Boston for its 6th year\, the 6th Treg-Directed Therapies Summit stands as the singular industry forum shining a spotlight on the groundbreaking research and clinical advancements in CAR-Treg and IL2 mutein therapies. Witness the convergence of leading industry and academic experts as they unite to propel the clinical efficacy of Treg therapies to new heights. \nAs the pioneering and longest-tenured meeting dedicated to optimizing and manipulating Treg-based approaches\, this summit invites you to become part of a community at the forefront of innovation. Gain unparalleled insights into the latest developments driving specificity\, delve into novel cell product design\, and explore the engineering of CAR-Tregs to enhance cell stability and durability. \nDon’t miss this unique opportunity to stay ahead in the dynamic landscape of Treg therapies. Join us and contribute to the ongoing dialogue that shapes the future of cutting-edge medical advancements. \nTo know more visit: https://ter.li/gfpnb0
URL:http://www.pharmajournalist.com/event/6th-annual-treg-directed-therapies-summit/
LOCATION:Hilton Boston Logan Airport\, One Hotel Dr\, Boston\, MA\, 02128\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240522
DTEND;VALUE=DATE:20240525
DTSTAMP:20260515T225136
CREATED:20240103T113206Z
LAST-MODIFIED:20240103T113206Z
UID:38410-1716336000-1716595199@www.pharmajournalist.com
SUMMARY:5th Gene Therapy Analytical Development Europe Summit
DESCRIPTION:The 5th Gene Therapy Analytical Development Europe – What to Expect in 2024? \nIn the face of evolving regulatory guidelines and mounting scrutiny\, the 5th Gene Therapy Analytical Development Europe Summit will discuss ways you can apply contemporary analytical tools to guarantee the consistency\, quality\, and safety of your gene therapy products. \nJoin leading CMC\, regulatory\, QC\, analytical and process development experts to gain access to novel data and recent case studies by industry professionals from AstraZeneca\, the MHRA\, Novartis\, Sarepta Therapeutics\, Roche\, Sanofi\, and many more. \nEnjoy in-depth\, valuable networking opportunities with scientists and senior decision makers from small biotech through to large pharma – perfect for those looking to further industry relationships. \nTo know more visit: https://ter.li/vz0jr4
URL:http://www.pharmajournalist.com/event/5th-gene-therapy-analytical-development-europe-summit/
LOCATION:15Hatfields\, Chadwick Court\, London\, SE1 8DJ\, United Kingdom
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR